Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     
  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    50,228.33
    +3,098.73 (+6.57%)
     
  • CMC Crypto 200

    1,363.89
    +86.91 (+6.81%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

BUZZ-Top of the Street: round-up of highly rated analyst action in Europe

Ratings & estimate changes by Europe's top-ranked* analysts:

** Active Biotech (Other OTC: ATVBF - news) : Goldman Sachs (NYSE: GS-PB - news) initiates with a buy rating, TASQ potential not factored into share price.

** Adidas AG (Other OTC: ADDDF - news) : drops off Credit Suisse Europe focus list, on FX and unhedged exposure to Russia, 4 of 5 analysts since March 5 have EPS estimates for the Mar-14 quarter, average revision -25.8%.

** Lloyds : Numis, 5-star analyst, upgrades to buy, equity cash-flow & steady dividend hikes in 2015, 2016.

** Bunzl (Frankfurt: BUZ1.F - news) : HSBC, 4-star analyst, hikes target price to 1700p, minimal EM exposure & potential for Europe surprises, valuation the key concern, sticks with neutral rating.

ADVERTISEMENT

** Saint Gobain (Berlin: GOB.BE - news) : Jefferies, 5-star analyst, resumes coverage with a buy rating, target price at 54, on Western Europe & US recovery.

** Amadeus : N+1 Equities, 5 star analyst, upgrades to buy on IHG contract.

** LVMH (TLO: LVMH.TI - news) : Deutsche upgrades to buy, expects stock to play catch-up to sector.

** Thales (Dusseldorf: CSF.DU - news) : JPMorgan, 4-star analyst, reiterates overweight ahead of co's first capital markets day in 4 years. Small upgrade to 2015-2017 EPS estimates.

* Analyst rankings from Thomson Reuters StarMine. Scale is from 1-star to 5-star with 5 being best. Analysts ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.

(Stocks Buzz is a pilot project. Please send any feedback or suggestions to vikram.subhedar@thomsonreuters.com) (RM (LSE: RM.L - news) : vikram.subhedar.thomsonreuters.com@reuters.net)